Osteogel BARRIER is a reliable, synthetic and user-friendly alternative to absorbable membranes. Osteogel Barrier Gel is composed of two-thirds cross-linked and one-third non-cross-linked hyaluronic acid. After the manufacturing process, the hyaluronic acid is crushed into particles of 150 to 200 micrometers and then added to the non-crosslinked hyaluronic acid. The defined particle size ensures a precise reproduction of the surface structure. After the uniform application of the barrier gel and a comparatively short resorption time of 6 to 12 hours for the non-cross-linked hyaluronic acid, a homogeneous layer of cross-linked particles remains on the defective area. The particles of different sizes condense and form a flexible membrane that covers the area to be protected. This barrier function is retained for 3 weeks. The material is finally completely resorbed within 2-3 weeks. The barrier function is guaranteed for 3 weeks. Osteogel Barrier is then resorbed locally by the surrounding tissue. Osteogel Barrier achieves biological protection of the tissue and thus prevents contamination of the surgical site over the entire resorption period.

Osteogel consists of non-cross-linked hyaluronic acid and has been specially designed for the treatment of inflammation of the oral mucosa and for improved or controlled wound healing after surgical procedures (GTR). The low viscosity of the hyaluronic acid liquid gel enables easy clinical application. Implantology: Activation of bone regeneration material with Osteogel optimizes handling, formability and accelerates wound healing. Increasing the formation of new osteoblasts to shorten bone regeneration. Support and acceleration of wound healing through anti-inflammatory properties (inhibition of the production of pro-inflammatory cytokines, e.g. TNF a). Reduced scarring in aesthetically demanding areas (HA matrix prevents the deposition of collagen and leads to less scarring). Periodontology: Support of the regeneration process after periodontal surgery through bacteriostatic effect (especially with Actinobacillus actionomyecetemcomitans, Prevotella intermedia & Staphylococcus aureus). Increase in bone level after HA-assisted periodontal therapySignificant improvement in the SBI (Sulcus Bleeding Index)